Characterization of preclinical Alzheimer's disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology.

Authors:
Huang X; Huang S; Fu F; Song J; Zhang Y and 1 more

Journal:
Alzheimers Res Ther

Publication Year: 2024

DOI:
10.1186/s13195-024-01416-9

PMCID:
PMC10921774

PMID:
38459540

Journal Information

Full Title: Alzheimers Res Ther

Abbreviation: Alzheimers Res Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approvalAll animal experiments were approved by Institutional Animal Care and Use Committee (IACUC, No. SSLI-21008) of Thinxon biomedical Co., Ltd. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was funded in part by the STI2030-Major Projects (2021ZD0200900); National Key Research and Development Project of China (2018YFA0108503); National Hainan Key Research and Development Project (ZDYF2021SHFZ049); Hainan Province Natural Science Foundation of high-level talent project (322RC588); and Project of Collaborative Innovation Center of One Health (XTCX2022JKC05)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025